医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
2-(4-溴-1H-吡唑-1-基)嘧啶 | 2-(4-bromo-1H-pyrazol-1-yl)pyrimidine | 857641-46-4 | C7H5BrN4 |
|
2-(4-氰基苯氧基)-5-(三氟甲基)吡啶 | 4-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzonitrile | 175277-01-7 | C13H7F3N2O |
|
2-(4-氯苯氧基)-5-硝基吡啶 | 2-(4'-chlorophenoxy)-5-nitropyridine | 28232-30-6 | C11H7ClN2O3 |
|
2-(4-氯苯氧基)-3-硝基吡啶 | 2-(4-chlorophenoxy)-3-nitropyridine | 76893-45-3 | C11H7ClN2O3 |
|
2-(4-氯苯基)嘧啶-5-甲醛 | 2-(4-chlorophenyl)pyrimidine-5-carbaldehyde | 928713-84-2 | C11H7ClN2O |
|
2-(4-氯苯基)喹啉-4-甲酸 | 2-(4-chlorophenyl)quinoline-4-carboxylic acid | 5466-31-9 | C16H10ClNO2 |
|
2-(4-氯苯基)哌嗪-1-羧酸叔丁酯 | 2-(4-chlorophenyl)-piperazine-1-carboxylic acid tert-butyl ester | 769944-39-0 | C15H21ClN2O2 |
|
2-(4-氯苯基)吡啶 | 2-(4-chlorophenyl)pyridine | 5969-83-5 | C11H8ClN |
|
2-(4-氯苯基)-4,4-二甲基-1-环己烯-1-羧醛 | 2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enecarbaldehyde | 1228837-05-5 | C15H17ClO |
|
2-(4-氯苯基)-2-(吡啶-2-基)乙腈 | 2-(4-chlorophenyl)-2-(pyridin-2-yl)acetonitrile | 5005-37-8 | C13H9ClN2 |
|
2-(4-氯苯乙酰基)苯甲酸 | 2‐(4-chlorophenylacetyl)benzoic acid | 53242-76-5 | C15H11ClO3 |
|
2-(4-氯嘧啶-5-基)乙酸 | 4-chloro-5-carboxymethylpyrimidine | 389799-46-6 | C6H5ClN2O2 |
|
2-(4-氯-2-甲基苯氧基)-3-硝基吡啶 | 2-(4-Chloro-2-methylphenoxy)-3-nitropyridine | 465514-31-2 | C12H9ClN2O3 |
|
2-(4-氨基苯基)丁酸 | 2-(4-aminophenyl)butanoic acid | 29644-97-1 | C10H13NO2 |
|
2-(4-氨基-2-乙氧基苯基)-1H-异吲哚-1,3(2H)-二酮 | 2-(4-amino-2-ethoxyphenyl)isoindole-1,3-dione | 106981-52-6 | C16H14N2O3 |
|
2-(4-氨基-1-(叔丁氧基羰基)哌啶-4-基)乙酸 | 4-amino-4-carboxymethylpiperidine-1-carboxylic acid tert-butyl ester | 1159983-30-8 | C12H22N2O4 |
|
2-(4-氟苯氧基)-3-硝基吡啶 | 2-(4-fluorophenoxy)-3-nitropyridine | 147143-58-6 | C11H7FN2O3 |
|
2-(4-氟苯基)噻吩 | 2-(4-fluorophenyl)thiophene | 58861-48-6 | C10H7FS |
|
2-(4-氟苯基)吲哚 | 2-(4-fluorophenyl)indole | 782-17-2 | C14H10FN |
|
2-(4-氟苯基)吡啶 | 4-fluorophenylpyridine | 58861-53-3 | C11H8FN |
|
2-(4-氟苯基)-哌嗪 | 2-(4-fluorophenyl)piperazine | 65709-33-3 | C10H13FN2 |
|
2-(4-氟苯基)-5-甲基吡啶 | 2-(4-fluorophenyl)-5-methylpyridine | 85237-65-6 | C12H10FN |
|
2-(4-氟苯基)-5-[(5-碘-2-甲基苯基)甲基]噻吩 | 2-(4-fluorophenyl)-5-(5-iodo-2-methylbenzyl)thiophene | 898566-17-1 | C18H14FIS |
|
2-(4-氟苯基)-1H-苯并咪唑 | 2-(4-fluorophenyl)-1H-benzoimidazole | 324-27-6 | C13H9FN2 |
|
2-(4-氟-苯基)-喹啉 | 2-(4-fluoro-phenyl)-quinoline | 323-91-1 | C15H10FN |
|
2-(4-戊炔氧基)四氢-2H-吡喃 | 1-(tetrahydropyranyloxy)-4-pentyn | 62992-46-5 | C10H16O2 |
|
2-(4-异氰基苯基)嘧啶 | 2-(4-Isocyanatophenyl)pyrimidine | 216059-84-6 | C11H7N3O |
|
2-(4-异丙基噻唑-2-基)-7-甲氧基-8-甲基喹啉-4-醇 | 2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-ol | 923289-21-8 | C17H18N2O2S |
|
2-(4-噻吩-2-基苯基)噻吩 | 1,4-bis(2-thienyl)benzene | 23354-94-1 | C14H10S2 |
|
2-(4-哌嗪-1-基-苯基)-嘧啶二盐酸盐 | 2-(4-piperazin-1-yl-phenyl)-pyrimidine hydrochloride | 1427195-19-4 | C14H16N4*ClH |
|
2-(4-哌啶基)-2-丙醇 | 2-(piperidin-4-yl)propan-2-ol | 22990-34-7 | C8H17NO |
|
2-(4-吡啶基)苯甲醛 | 2-(pyridin-4-yl)benzaldehyde | 176526-00-4 | C12H9NO |
|
2-(4-吡啶基)-4-氨基嘧啶 | 2-(4-pyridinyl)-4-pyrimidinamine | 61310-29-0 | C9H8N4 |
|
2-(4-吡啶基)-4-喹啉羧酸 | 2-(pyridin-4-yl)quinoline-4-carboxylic acid | 14228-23-0 | C15H10N2O2 |
|
2-(4-吡啶基)-2-丙胺 | 2-(pyridin-4-yl)propan-2-amine | 566155-76-8 | C8H12N2 |
|
2-(4-吡啶-4-基苯基)乙腈 | 2-(4-(pyridin-4-yl)phenyl)acetonitrile | 112170-33-9 | C13H10N2 |
|
2-(4-吡啶)苯并咪唑 | 2-(pyridin-4-yl)-1H-benzo[d]imidazole | 2208-59-5 | C12H9N3 |
|
2-(4-吡啶)吗啉 | 2-(pyridin-4-yl)morpholine | 1018656-57-9 | C9H12N2O |
|
2-(4-吗啡啉基)嘧啶-5-硼酸嚬哪醇酯 | 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl)morpholine | 957198-30-0 | C14H22BN3O3 |
|
2-(4-吗啉基)异烟酸 | 2-morpholin-4-ylisonicotinic acid | 295349-64-3 | C10H12N2O3 |
|
2-(4-吗啉基)喹啉-3-甲醛 | 2-morpholinoquinoline-3-carbaldehyde | 326008-62-2 | C14H14N2O2 |
|
2-(4-吗啉基)-5-嘧啶甲醛 | 2-(morpholin-4-yl)pyrimidine-5-carbaldehyde | 842974-69-0 | C9H11N3O2 |
|
2-(4-吗啉基)-3-氯吡啶 | 4-(3-chloropyridin-2-yl)morpholine | 54231-36-6 | C9H11ClN2O |
|
2-(4-吗啉基)-16-(1-吡咯基)-雄甾-3,17-二醇 | (2β,3α,5α,16β,17β)-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane-3,17-diol | 119302-20-4 | C27H46N2O3 |
|
2-(4-叔丁苯基)吡啶 | 2-(4-tert-butylphenyl)pyridine | 524713-66-4 | C15H17N |
|
2-(4-叔丁氧基甲酰基哌嗪基)-2-苯乙酸 | 2-(4-(tert-butoxycarbonyl)piperazin-1-yl)-2-phenylacetic acid | 347186-49-6 | C17H24N2O4 |
|
2-(4-乙烯基吡啶-2-基)-4-甲基吡啶 | 4-vinyl-4'-methyl-2,2'-bipyridine | 74173-48-1 | C13H12N2 |
|
2-(4-(氯甲基)苯基)-5-氟嘧啶 | Pyrimidine, 2-[4-(chloromethyl)phenyl]-5-fluoro- | 1139432-30-6 | C11H8ClFN2 |
|
2-(4-(叔丁氧羰基)苯基)-2,2-二氟乙酸 | 2-(4-(Tert-butoxycarbonyl)phenyl)-2,2-difluoroacetic acid | 1211594-71-6 | C13H14F2O4 |
|
2-(4-(三氟甲基)吡啶-2-基)乙腈 | 2-(4-(Trifluoromethyl)pyridin-2-yl)acetonitrile | 1000536-10-6 | C8H5F3N2 |
|